Mashup Score:294
NatureNon-viral precision T cell receptor replacement for personalized cell therapy - 6 days
Mashup Score:294
Specialty: General Medicine (Journals and Societies)
Mashup Score:259
The BMJFDA oversight of clinical trials is “grossly inadequate,” say experts - 1 week
Mashup Score:259
Covid-19 vaccines and drugs were developed at “warp speed” and now experts are concerned that the US Food and Drug Administration inspected too few...
-
Investigation: #Covid-19 vaccines and drugs were developed at “warp speed” and now experts are concerned about the US FDA's inadequate surveillance of clinical trial sites, finds journalist @MaryanneDemasi in @bmj_latest 📖▶️ https://t.co/X5PCUMwKG0 https://t.co/X5PCUMwKG0 - view on twitter
More coverage:
#covid
Mashup Score:162
The BMJClimate crisis: Doctors found not guilty of public disorder over Lambeth Bridge blockade - 1 week
Mashup Score:162
Six doctors and a nurse have been acquitted of breaching public order laws by a London court. The City of London magistrates’ court ruled...
-
Six doctors and a nurse have been acquitted of breaching public order laws by a London court after they had blocked Lambeth Bridge on Sunday 10 April. They had joined the group Extinction Rebellion in a protest earlier that day https://t.co/iw6p1BMTXt - view on twitter
Mashup Score:154
The BMJFDA oversight of clinical trials is “grossly inadequate,” say experts - 1 week
Mashup Score:154
Covid-19 vaccines and drugs were developed at “warp speed” and now experts are concerned that the US Food and Drug Administration inspected too few...
-
Covid-19 vaccines and drugs were developed at “warp speed” and now experts are concerned that the US Food and Drug Administration inspected too few clinical trial sites. Maryanne Demasi reports https://t.co/r8kVau5qWx - view on twitter
Mashup Score:107
New England Journal of Medicine (NEJM)Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali | NEJM - 4 days
Mashup Score:107
Original Article from The New England Journal of Medicine — Safety and Efficacy of a Monoclonal Antibody against Malaria in...
-
ICYMI: The authors of this Original Article conducted a phase 2 trial to assess the safety and efficacy of antimalarial monoclonal antibody against P. falciparum infection in healthy adults in Mali over a 6-month malaria season. https://t.co/UGeBHOPhKY https://t.co/UGeBHOPhKY - view on twitter
Mashup Score:93
NatureA multinational Delphi consensus to end the COVID-19 public health threat – Nature - 4 days
Mashup Score:93
A diverse, multidisciplinary panel of 386 experts in COVID-19 response from 112 countries provides health and social policy actions to address inadequacies in the...
-
A @Nature paper presents recommendations on how to end the COVID-19 public health threat from a panel of 386 researchers, clinicians and policy advisors. The paper outlines the health and social actions that need to be taken to end this global threat. https://t.co/XfO9LQ5gS1 https://t.co/XfO9LQ5gS1 - view on twitter
Mashup Score:91
New England Journal of Medicine (NEJM)Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease | NEJM - 6 days
Mashup Score:91
Original Article from The New England Journal of Medicine — Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular...
-
ICYMI: Michelle L. O’Donoghue, M.D., M.P.H., et al. report on a trial that tested the effects of an oligonucleotide drug targeting apolipoprotein(a) mRNA on lipoprotein(a) concentrations in patients with CVD. https://t.co/eLgnrnTm5D https://t.co/eLgnrnTm5D - view on twitter
Mashup Score:90
NatureAPOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes - 5 days
Mashup Score:90
APOE4 is the strongest genetic risk factor for Alzheimer’s disease1–3. However, the effects of APOE4 on the human brain are not fully understood, limiting...
-
APOE4 is the strongest genetic risk factor for Alzheimer’s disease. A study in @Nature establishes a functional link between APOE4, cholesterol, myelination and memory, offering therapeutic opportunities for Alzheimer’s disease. https://t.co/bNsmDVPfFW https://t.co/bNsmDVPfFW - view on twitter
Mashup Score:89
New England Journal of Medicine (NEJM)Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination | NEJM - 3 days
Mashup Score:89
Correspondence from The New England Journal of Medicine — Neutralization of Omicron Subvariant BA.2.75 after Bivalent...
-
Serum from persons who received a booster dose with the omicron sequence–containing mRNA-1273.214 vaccine showed cross-neutralization activity against omicron variants that are not components of the vaccine. https://t.co/E8nfl0KLsO https://t.co/E8nfl0KLsO - view on twitter
Mashup Score:88
The BMJChanging the perspective on low birth rates: why simplistic solutions won’t work - 1 week
Mashup Score:88
Stuart Gietel-Basten , Anna Rotkirch , and Tomáš Sobotka argue that policies responding to population decline and ageing should enable reproductive choice and maximise...
-
Many governments have introduced target driven policies to spur birth rates. These policies often negatively affect gender equity, reproductive health, and sexual rights and are unlikely to be successful, says Analysis @stuartbasten @AnnaRotkirch https://t.co/k1vsKFfYhZ - view on twitter
The T cell receptor (TCR) provides the fine specificity of T cells to recognize mutations in cancer cells 1-3. We developed a clinical-grade approach...
A paper in @Nature describes the development and first-in-human clinical testing of non-virally engineered immune cells for cancer therapy. The approach uses CRISPR genome editing to produce patient-specific T cells. https://t.co/iVW3rTjAOH https://t.co/iVW3rTjAOH - view on twitter